Build AI-Ready Pharma R&D to Accelerate Drug Development

Pharma R&D is at a crossroads: the pressure to accelerate innovation, ensure compliance and manage fragmented data has never been greater. This webinar explores how leading organizations are operationalizing AI across discovery and development, without compromising scientific rigor or compliance.

Attendees will learn how agentic AI, unified data platforms and digital twins are transforming the pace and quality of research. The featured speaker will examine real-world case studies from customers, showing how modular AI platforms and predictive analytics are driving faster, safer and more compliant drug development.

The webinar will explore how organizations are building AI fluency into workflows and creating a foundation for scalable innovation.

For R&D leaders, clinical trial teams, regulatory affairs professionals and digital transformation teams, this session will clarify how to move from fragmented manual processes to a cohesive agentic operating model.

Register for this webinar to learn how AI-ready R&D can accelerate innovation and improve drug development in regulated pharma. This webinar is part of 4-part series.

Speaker

Elena Bonfiglioli, Global Business Leader Healthcare, Pharma and Life Sciences International Clinical Applications GM, Microsoft

Elena is Microsoft’s Global Business Leader for Healthcare and Life Sciences, responsible for global commercial strategy, go-to-market and AI-driven transformation across providers, payors and life sciences organizations. She leads a global team driving customer engagement, partnerships and pipeline growth, and oversees sales for Dragon Copilot Clinical Applications outside the US.

A recognized industry leader, Elena serves on multiple advisory boards, including the DIA Pharma Advisory Council (EMEA) and the Kearney Women’s Health Community, and holds board roles across startups and global health initiatives. She has been named a Top 50 AI Innovator twice.

Her work has advanced landmark AI partnerships with organizations like Novartis and led major initiatives in population health, cancer prevention and women’s health equity. With over 20 years in healthcare, Elena is a global thought leader and advocate for data-driven innovation, health equity and inclusive leadership.

Message Presenter